Related Experiment Video
Updated: Jun 28, 2026

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model
Published on: October 10, 2017
Mesoporous Catalytic-Adsorptive Nanoregulator Orchestrates Biofilm eDNA/LPS Disassembly and TLR9/TLR4 Immune
Junfeng Song1, Yang Song1, Xirui Huang1
1Lab of Advanced Materials, College of Smart Materials and Future Energy, Department of Chemistry, Fudan University, Shanghai, China.
A novel nano-regulator, CT/mAPF, effectively combats chronic diabetic foot infections by disrupting biofilms, eradicating bacteria, and neutralizing inflammation. This approach targets extracellular DNA and lipopolysaccharides, accelerating wound healing in diabetic models.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Infectious Diseases
Background:
- Chronic diabetic foot infections involve biofilms and hyperinflammation, driven by extracellular DNA (eDNA) and lipopolysaccharides (LPS).
- These factors create structural resistance and immune interference, hindering conventional therapies.
- The TLR4/9 signaling axis is implicated in the inflammatory response.
Purpose of the Study:
- To develop a multifunctional nano-regulator for treating chronic diabetic foot infections.
- To address biofilm disruption, bacterial eradication, and debris neutralization simultaneously.
- To investigate the nano-regulator's efficacy in resolving infection and inflammation cycles.
Main Methods:
- Development of a Colistin (CT) and m-aminophenol formaldehyde (mAPF) based nano-regulator (CT/mAPF).
- Assessment of bactericidal activity and biofilm disruption via ROS-mediated eDNA fragmentation.
- Evaluation of LPS neutralization, eDNA degradation, and TLR4/9 pathway silencing.
- In vivo studies using diabetic mouse models to assess wound healing, bacterial clearance, and inflammatory markers.
Main Results:
- CT/mAPF demonstrated potent bactericidal activity (99.99%) and effective biofilm scaffold destruction.
- The nano-regulator neutralized LPS and degraded eDNA, silencing TLR4 and TLR9 signaling.
- Significant reduction in pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) was observed.
- Accelerated wound closure, enhanced angiogenesis, and collagen maturation were noted in diabetic mouse models.
Conclusions:
- The CT/mAPF nano-regulator offers an integrated strategy to overcome dual resistance in diabetic foot infections.
- This approach effectively resolves chronic infection and inflammation by targeting biofilms and immune responses.
- CT/mAPF presents a promising therapeutic candidate for Gram-negative bacteria-infected diabetic wounds.
Related Concept Videos
Diabetic Foot Ulcer
Gene Regulation in Microbial Communities: Quorum Sensing
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Biofilms
